The FDA should immediately reinstate the in-person dispensing requirement for mifepristone

From the articleFDA's abortion pill safety review continuing into next year angers abortion rights opponentsAlso in Abortion drug safety review will be completed by March, US FDA says | Reuters, FDA says it will complete safety review of abortion pill in March, DA Says It Won't Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety Concerns